Business

Brian Niccol, CEO of Chipotle Mexican Grill Adam Jeffery | CNBC Chipotle Mexican Grill said Thursday that executive compensation will now be linked to hitting targets tied to the company’s environmental and diversity goals. The burrito chain is following in the footsteps of Starbucks and McDonald’s, both of which recently announced that performance for racial
0 Comments
A Nordstrom store in Irvine, California. Scott Mlyn | CNBC Nordstrom on Tuesday reported fourth-quarter sales and earnings that topped analysts’ estimates, thanks to stronger shopper demand online and growth at its off-price Nordstrom Rack business. But the company cautioned that it has been recently impacted by shipping delays, which held up some of its
0 Comments
Gary Collis of Bunker Hill, West Virginia, receives his boost dose at a coronavirus disease (COVID-19) community vaccination event, as the vaccination rate in West Virginia ranks among highest in world, in Martinsburg, February 25, 2021. Kevin Lamarque | Reuters Johnson & Johnson‘s Covid-19 vaccine can be used as a substitute for a second jab
0 Comments
Johnson & Johnson Coronavirus vaccine illustration Dado Ruvic | Reuters An advisory panel to the Centers for Disease Control and Prevention voted unanimously Sunday to recommend the use of Johnson & Johnson‘s one-shot Covid-19 vaccine as the federal government prepares to ship out millions of doses this week. Once CDC Director Dr. Rochelle Walensky accepts
0 Comments
The Food and Drug Administration has approved Johnson & Johnson‘s Covid-19 vaccine for emergency use, giving the United States a third tool to fight the pandemic as highly contagious variants start to take root across the country. The FDA’s emergency use authorization Saturday kickstarts the federal government’s plan to distribute nearly 4 million doses of
0 Comments
A key Food and Drug Administration advisory panel on Friday unanimously backed Johnson & Johnson‘s single-shot coronavirus vaccine for emergency use, a critical step paving the way to distribute a third preventative treatment in the U.S. next week. The nonbinding decision, which was adopted 22-0, by the FDA’s Vaccines and Related Biological Products Advisory Committee
0 Comments